Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Papillomavirus Infections × Engerix-B × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 3 Viral Load 1 Transurethral Resection of Prostate 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Engerix-B 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01082861 2010-03-19

TANGO

National Institute for Public Health and the Environment (RIVM)

Phase 4 Terminated

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡